After Lundbeck bought the rights to two drugs that treat a life-threatening heart condition in low birth weight babies and raised the price 13-fold, the FTC sued. On Friday, the 8th Circuit upheld a ruling that the government failed to show the drugs were in the same product market.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *